Tongling Bionic Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series B2

  • Investors
  • 9

Tongling Bionic General Information

Description

Provider of heart failure diagnosis, treatment and rehabilitation designed for heart failure patients. The company focuses on researching and developing series of medical plan and assisting equipment, enabling patients to be treated and recovered efficiently.

Contact Information

Website
www.telelife.com.cn
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building A7, National Health Big Data Industrial Park
  • Hefei, Anhui 230093
  • China
+86 400
Primary Industry
Clinics/Outpatient Services
Vertical(s)
Life Sciences
Corporate Office
  • Building A7, National Health Big Data Industrial Park
  • Hefei, Anhui 230093
  • China
+86 400

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tongling Bionic Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series B2) 13-Jan-2026 Completed Generating Revenue
9. Later Stage VC (Series B1) 05-Nov-2025 Completed Generating Revenue
8. Secondary Transaction - Private 20-May-2024 Completed Generating Revenue
7. Later Stage VC 31-May-2022 Completed Generating Revenue
6. Later Stage VC (Series B) 01-Mar-2022 Completed Generating Revenue
5. Early Stage VC (Series A1) 26-Apr-2021 Completed Generating Revenue
4. Secondary Transaction - Private 15-Jan-2021 Completed Generating Revenue
3. Early Stage VC 01-Dec-2020 Completed Generating Revenue
2. Secondary Transaction - Private 21-Sep-2020 Completed Generating Revenue
1. Early Stage VC 24-Oct-2017 Completed Generating Revenue
To view Tongling Bionic’s complete valuation and funding history, request access »

Tongling Bionic Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • Pending

  • Expiring in next 12 mo

Tongling Bionic Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
DE-202022105810-U1 Interventional combined cardio-renal assistance system Active 19-Jul-2022
DE-202022100025-U1 Dosing device for the manufacture of a blood pump Active 12-Oct-2021

Tongling Bionic Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Changchun Equity Investment Fund Management Growth/Expansion Minority
Beijing Wenzhi Private Equity Fund Management Growth/Expansion Minority
The Chinese Academy of Sciences Venture Capital Management Venture Capital Minority
Pine Venture Capital Growth/Expansion Minority
SY Capital Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

Tongling Bionic FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process